Arcus Biosciences, Inc.
RCUS
$9.34
-$0.20-2.10%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.17% | 1.08% | -2,225.00% | 95.06% | -14.08% |
| Total Depreciation and Amortization | 50.00% | 0.00% | -33.33% | 0.00% | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.67% | -6.25% | -55.56% | 157.14% | -12.50% |
| Change in Net Operating Assets | -122.77% | 631.58% | 48.65% | -54.17% | -166.67% |
| Cash from Operations | -484.62% | 127.66% | -4,600.00% | 97.73% | -39.68% |
| Capital Expenditure | 0.00% | -- | 100.00% | 33.33% | 40.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 285.71% | -144.44% | 138.18% | -585.29% | 61.90% |
| Cash from Investing | 275.86% | -146.03% | 137.28% | -703.57% | 154.55% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.00% | -33.33% | -98.69% | 7,533.33% | -50.00% |
| Repurchase of Common Stock | -400.00% | 0.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.17% | 2,300.00% | -99.13% | 7,533.33% | -50.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.33% | 255.17% | -150.00% | 201.75% | -23.91% |
